Key facts
- Notable investors include Xi'an High-tech Industry Venture Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Xi'an Haorui Gene Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Xi'an Haorui Gene Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Xi'an Haorui Gene Technology
Developer of a genetic technology platform designed to advance clinical molecular diagnostics through third-generation single-molecule sequencing. The company offers cutting-edge sequencing infrastructure, a highly specialized research team, and strategic partnerships with global technology leaders, enabling biomedical researchers and healthcare institutions to access precise genomic insights and redefine standards in clinical diagnostics.
- Sector
- Healthcare
- HQ
- Xi'an, China
- Founded
- 2019
- Employees
- 3
- Website
- xahorizon.cn/
- Ownership
- Privately Held (backing)
Xi'an Haorui Gene Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xi'an Haorui Gene Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xi'an Haorui Gene Technology in its N-PORT filings yet. We sweep new filings monthly.